Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

SHPH Shuttle Pharmaceuticals

Watchlist
3.910
-0.680-14.81%
Close 10/03 16:00 ET
3.830
-0.08-2.05%
Pre Mkt Price 10/04 05:31 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
4.590
Open
4.480
Turnover
4.69M
Low
3.850
Pre Close
4.590
Volume
1.16M
Market Cap
51.94M
P/E(TTM)
Loss
52wk High
126.260
Shares
13.28M
P/E(Static)
Loss
52wk Low
3.850
Float Cap
4.79M
Bid/Ask %
33.33%
Historical High
126.260
Shs Float
1.23M
Volume Ratio
0.30
Historical Low
3.850
Dividend TTM
--
Div Yield TTM
--
P/B
-22.47
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
94.34%
Amplitude
16.12%
Avg Price
4.053
Lot Size
1
Float Cap
4.79M
Bid/Ask %
33.33%
Historical High
126.260
Shs Float
1.23M
Volume Ratio
0.30
Historical Low
3.850
Dividend TTM
--
P/B
-22.47
Dividend LFY
--
Turnover Ratio
94.34%
Amplitude
16.12%
Avg Price
4.053
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers. The company was founded in 2012 and is based in Rockville, Maryland.
CEO: Dritschilo M.D., Anatoly
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top